Prilenia Therapeutics is planning to file its Huntington’s disease ... HD address the symptoms of the disease, and pridopidine is vying to become the first drug approved to slow down its ...

According to the University of California San Francisco, Huntington’s disease affects one in every 10,000 to 20,000 people in ...

Management of dysphagia in people with Huntington’s disease can be complicated. Many of the medications to help manage Huntington’s disease symptoms, such as antipsychotic medications and ...

A 14-year study tracking NfL levels in people with the HD gene shows this tiny protein can signal disease progression many ...

Huntington’s disease is an inherited neurological disorder causing movement, cognitive, and behavioral issues. Effective management includes medical treatments, therapies, nutritional support, and ...

Huntington’s disease was long thought to be caused by the slow buildup of a toxic protein, but new research has reveale | This week on "The Top Line," we hear from Steven McCarroll, Ph.D., whose ...

However, managing complications of Huntington’s disease can involve a combination of medications and supportive care. This article explores some of the most frequently asked questions about the ...

HDBuzz reported live updates on Bluesky from the 2025 HD Therapeutics Conference. Read on for coverage of Day 1. #CHDI2025 ...

LETI-101 has demonstrated therapeutically relevant reductions of mutant huntingtin (HTT) protein, exceeding 80%, while preserving essential ...